Update on universal childhood immunizations

Current Opinion in Pediatrics

Volumn 20, Issue 4, 2008, Pages 483-489

  Hamlin, Jean ^a   Senthilnathan, Selvi ^a   Bernstein, Henry H ^a  

^a CHILDREN S HOSPITAL AT DARTMOUTH   (United States)

Author keywords

Combination vaccines; Immunization; Vaccine; Vaccine safety

Indexed keywords

AMANTADINE; CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; CHICKENPOX VACCINE; HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS CONJUGATE VACCINE; MENINGOCOCCUS POLYSACCHARIDE VACCINE; MENINGOCOCCUS VACCINE; OSELTAMIVIR; PNEUMOCOCCUS VACCINE; RIMANTADINE; TRIHIBIT; UNCLASSIFIED DRUG; WART VIRUS VACCINE; ZANAMIVIR; HAEMOPHILUS VACCINE; MUMPS VACCINE; STREPTOCOCCUS VACCINE;

CHICKENPOX; CHILDHOOD; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; FEBRILE CONVULSION; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; INFECTION; INFLUENZA; INFLUENZA VACCINATION; MEASLES; MEASLES VACCINATION; MUMPS; NEISSERIA MENINGITIDIS; PERSISTENT INFECTION; PNEUMOCOCCAL INFECTION; PRECANCER; PRIORITY JOURNAL; REVIEW; RUBELLA; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VIRUS INFECTION; WART VIRUS; ADVISORY COMMITTEE; CHILD; HEALTH CARE PLANNING; IMMUNIZATION; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; STANDARD;

ADVISORY COMMITTEES; CHICKENPOX VACCINE; CHILD; HAEMOPHILUS VACCINES; HEALTH PLANNING GUIDELINES; HUMANS; IMMUNIZATION; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; INFLUENZA VACCINES; MENINGOCOCCAL VACCINES; MUMPS VACCINE; PAPILLOMAVIRUS VACCINES; PRACTICE GUIDELINES AS TOPIC; STREPTOCOCCAL VACCINES;

EID: 52449122535     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e328306ebd1     Document Type: Review

References (32)

1. Centers for Disease Control and Prevention. Recommended immunization schedules for persons aged 0-18 years-United States, 2008. MMWR 2008; 57:Q1 -Q4.
2. Centers for Disease Control and Prevention. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 2007; 56:1 -54.
3. Centers for Disease Control and Prevention. Press Release CORRECTION: CDC's Advisory Committee recommends influenza vaccination for children 6 monthsthrough 18yearsofage; 2008. http://www.cdc.gov/print.do?url=http %3A//www.cdc.gov/od/oc/media/pressrel/2008/r080227.htm. [Accessed 4 April 2008]
4. American Academy of Pediatrics, Committee on Infectious Diseases. Prevention of influenza: recommendations for influenza immunization of children, 2007-2008. Pediatrics 2008; 121:e101 6-e1031.
5. Centers for Disease Control and Prevention. Update: influenza activity: United States, September 30, 2007 - April 5, 2008, and composition of the 2008-09 influenza vaccine. MMWR 2008; 57:404-409.
6. Belongia E, Kieke B, Coleman L, et al. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine: Marshfield, Wisconsin, 2007-08 influenza season. MMWR 2008; 57:393-398.
7. Belshe RB, Edwards KM, Vesikari T, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007; 356:685-696.
8. Centers for Disease Control and Prevention. Quadrivalent human papillomavirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Early Release 2007; 56:1 -24.
9. American Academy of Pediatrics, Committee on Infectious Diseases. Recommended immunization schedules for children and adolescents: United States, 2008. Pediatrics 2008; 121:219-220.
10. American Academy of Pediatrics. Vaccine administration. In: Pickering LK, Baker CJ, Long SS, McMillan JA, editors. Red book: 2006 report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village: American Academy of Pediatrics; 2006. pp. 18-22.
11. Winer RL, Hughes JP, Feng Q, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006; 354:2645-2654.
12. Winer RL, Lee SK, Hughes JP, et al. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003; 157:218-226.
13. Winer RL, Feng Q, Hughes JP, et al. Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis 2008; 197: 279-282.
14. Partridge JM, Hughes JP, Feng Q, et al. Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students. J Infect Dis 2007; 196:1128-1136.
15. Centers for Disease Control and Prevention. Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 24-59 months who are not completely vaccinated. MMWR 2008; 57:343-344.
16. American Academy of Pediatrics. Pneumococcal infections. In: Pickering LK, editor. Red book: 2006 report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village: American Academy of Pediatrics; 2006. pp. 525-537.
17. Hicks LA, Harris LH, Flannery B, et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2008; 196:1346-1354.
18. Centers for Disease Control and Prevention. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction: eight states, 1998-2005. MMWR 2008; 57:144-148.
19. Pichichero M, Case JR. Emergence of a multiresistant serotype 19A pneu-mococcal strain not included in the 7-valent conjugate vaccine as an oto-pathogen in children. JAMA 2007; 298:1772-1778.
20. Centers for Disease Control and Prevention. Recommended immunization schedules for persons aged 0-18 years: United States, 2007. MMWR 2006; 55:Q1-Q4.
21. Kalies J, Grote V, Verstraeten T, et al. The use of combination vaccines has improvedtimelinessof vaccination in children. PediatrInfect Dis J 2006; 25:507-51 2.
22. Centers for Disease Control and Prevention. Combination vaccines for childhood immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP). MMWR 1999; 48:1 -15.
23. Centers for Disease Control and Prevention. Update: recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine. MMWR 2008; 57:258-260.
24. Johnston MV. Seizures in childhood. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, editors. Nelson textbook of pediatrics. 18th ed. Philadelphia: Saunders; 2007. http://www.mdconsult.com/das/book/body/93104834-3/ 0/1608/1343.html. [Accessed 24 April 2008]
25. Shinefield H, Black S, Laura D, et al. Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children. Pediatr Infect Dis J 2005; 24:665-669.
26. Hviid A, Rubin S, Muhlemann K. Mumps. Lancet 2008; 371:932-944.
27. Dayan GH, Quinlisk P, Parker AA, et al. Recent resurgence of mumps in the United States. N Engl J Med 2008; 358:1580-1589.
28. Savage E, White JM, Brown DEW, et al. Mumps epidemic: United Kingdom, 2004-2005. MMWR 2006; 55:173-175.
29. Centers for Disease Control and Prevention. Interim recommendations for the use of Haemophilus influenzae type b (Hib) conjugate vaccines related to the recall of certain lots of Hib-containing vaccines (PedvaxHIB and Comvax). MMWR Morb Mortal Wkly Rep 2007; 56:1318-1320.
30. American Academy of Pediatrics. Meningococcal infections. In: Pickering LK, editor. Red book: 2006 report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village: American Academy of Pediatrics; 2006. pp. 452-460.
31. Centers for Disease Control and Prevention. Notice to readers: recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of quadrivalent meningococcal conjugate vaccine (MCV4) in children aged 2-10 years at increased risk for invasive meningococcal disease. MMWR 2007; 56:1265-1266.
32. Centers for Disease Control and Prevention. Notice to readers: revised recommendations of the Advisory Committee on Immunization Practices to vaccinate all persons aged 11-18 years with meningococcal conjugate vaccine. MMWR 2007; 56:794-795.